Clinical Trial Update: Safety and Immunological Response Rate Study of THERATOPE® Vaccine in Metastatic Breast Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 study assessing safety and immunological response to the THERATOPE vaccine in metastatic breast cancer patients. The trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• THERATOPE

Snippet

Sponsor: Oncothyreon Canada Inc. | Conditions: Breast Neoplasms | Phase 2 | Status: COMPLETED